Efficacy of selpercatinib after prior systemic therapy in patients with RET mutant medullary thyroid cancer.

被引：3
|
作者：
Wirth, Lori J.
Sherman, Eric Jeffrey
Weiler, Daniela
Cabanillas, Maria E.
Robinson, Bruce
Italiano, Antoine
Laskin, Janessa J.
Subbiah, Vivek
Drilon, Alexander E.
Soldatenkova, Victoria
French, Pearl Plernjit
Wright, Jennifer
Kroiss, Matthias
Shah, Manisha H.
机构：
[1] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Kantonsspital Luzern, Arth, Switzerland
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Royal North Shore Hosp, St Leonards, NSW, Australia
[6] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
[7] Univ British Columbia, BC Canc, Vancouver, BC, Canada
[8] Weill Cornell Med Coll, New York, NY USA
[9] Eli Lilly & Co, Indianapolis, IN 46285 USA
[10] Univ Utah, Salt Lake City, UT USA
[11] Univ Hosp Wuerzburg, Wurzburg, Germany
[12] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.6074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6074
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Erectile Dysfunction in Patients Treated with Selpercatinib for RET-Altered Thyroid Cancer
    Matrone, Antonio
    Kroiss, Matthias
    Gild, Matti L.
    Hamidi, Sarah
    Sayehli, Cyrus Michael
    Siddal, Rhonda
    Gambale, Carla
    Prete, Alessandro
    Hu, Mimi I.
    Robinson, Bruce G.
    Elisei, Rossella
    THYROID, 2024,
  • [22] Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial
    Wirth, Lori J.
    Robinson, Bruce
    Boni, Valentina
    Tan, Daniel S. W.
    McCoach, Caroline
    Massarelli, Erminia
    Hess, Lisa M.
    Jen, Min-Hua
    Kherani, Jennifer
    Olek, Elizabeth
    Subbiah, Vivek
    ONCOLOGIST, 2022, 27 (01): : 13 - 21
  • [23] Medullary thyroid cancer: focus on systemic therapy
    Kiesewetter, Barbara
    Raderer, Markus
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2020, 13 (04): : 182 - 188
  • [24] Efficacy of selpercatinib as tyrosine kinase inhibitor in RETmutant medullary thyroid cancer: a systematic review
    Margouw, R. Relia
    Santoso, A. Febrian
    Maulidia, S. Azrianindita
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1330 - S1330
  • [25] Significant response of medullary thyroid cancer choroidal metastases to highly selective RET inhibitor selpercatinib: a case report
    Matrone, A.
    Prete, A.
    Sartini, S.
    Elisei, R.
    ANNALS OF ONCOLOGY, 2021, 32 (11) : 1447 - 1449
  • [26] Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET–mutant thyroid cancer
    Wenjing Chen
    Sophie Dream
    Pui-Yin Leung
    Pui-Kei Wu
    Stuart Wong
    Jong-In Park
    npj Precision Oncology, 8
  • [27] Durable Efficacy of Selpercatinib in Patients (pts) with Medullary Thyroid Cancer (MTC): Update of the LIBRETTO-001 Trial
    Kroiss, M.
    Sherman, E.
    Wirth, L. J.
    Cabanillas, M. E.
    Robinson, B.
    Subbiah, V.
    Drilon, A.
    Godbert, Y.
    Fasnacht, N.
    Soldatenkova, V.
    Xia, M. S.
    Duann, C. -W.
    Wright, J.
    Shah, M.
    SWISS MEDICAL WEEKLY, 2022, 152 : 46S - 47S
  • [28] Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial
    Kroiss, M.
    Sherman, E. J.
    Wirth, L. J.
    Cabanillas, M. E.
    Robinson, B.
    Subbiah, V.
    Drilon, A. E.
    Godbert, Y.
    Fasnacht, N.
    Soldatenkova, V.
    Xia, M. S.
    Duann, C-W.
    Wright, J.
    Weiler-Bisig, D.
    Shah, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1299 - S1300
  • [29] Medullary thyroid cancer. Review of 28 patients
    Pulgar B, Dahiana
    Jans B, Jaime
    Petric G, Militza
    Leon R, Augusto
    Camus A, Mauricio
    Goni E, Ignacio
    Dominguez C, Francisco
    Droppelmann M, Nicolas
    Claure S, Raul
    Gonzalez D, Hernan
    REVISTA MEDICA DE CHILE, 2013, 141 (11) : 1395 - 1401
  • [30] Germline Mutations of RET in Korean Patients with Medullary Thyroid Cancer
    Chun, S.
    Lee, W.
    Bae, M.
    Kim, S.
    Kim, T.
    Kim, W.
    Shong, Y.
    Hong, S.
    Min, W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 640 - 640
12345